Intec Parent (Intec Parent) Total Inventories : $0.00 Mil (As of Mar. 2021)

View and export this data going back to 1996. Start your Free Trial

What is Intec Parent Total Inventories?

Intec Parent's total inventories for the quarter that ended in Mar. 2021 was $0.00 Mil. Intec Parent's average total inventories from the quarter that ended in Dec. 2020 to the quarter that ended in Mar. 2021 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Intec Parent's Net-Net Working Capital per share for the quarter that ended in Mar. 2021 was $3.60.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intec Parent Total Inventories Historical Data

The historical data trend for Intec Parent's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intec Parent Total Inventories Chart

Intec Parent Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Total Inventories

Get a 7-Day Free Trial

Intec Parent Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Total Inventories	Get a 7-Day Free Trial															-	-	-	-	-

Intec Parent Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Intec Parent (NAS:NTEC) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Intec Parent's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2021 is

	Net-Net Working Capital Per Share (Q: Mar. 2021 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(10.135	+	0.75 * 0	+	0.5 * 0	-	6.086
-	0	-	0)	/	1.12564
=	3.60

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Intec Parent's Days Inventory for the three months ended in Mar. 2021 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2021 )	/	Cost of Goods Sold (Q: Mar. 2021 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Intec Parent's Inventory Turnover for the quarter that ended in Mar. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2021 )	/	Average Total Inventories (Q: Mar. 2021 )
	=	0	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intec Parent's Inventory to Revenue for the quarter that ended in Mar. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2021 )	/	Revenue (Q: Mar. 2021 )
	=	0	/	0
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Intec Parent Total Inventories Related Terms

Thank you for viewing the detailed overview of Intec Parent's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Intec Parent (Intec Parent) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intec Parent Inc (NAS:NTEC) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Hartom Street, Har Hotzvim, Jerusalem, ISR, 9777512

Website

https://www.intecpharma.com

Intec Parent Inc, formerly Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Israel. The company is focused on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. Accordion Pill Carbidopa/Levodopa or AP-CDLD is being developed by the company for the indication of treatment of Parkinson's disease.

Executives

Walt Addison Linscott	officer: Chief Business Officer	1860 MONTREAL ROAD, TUCKER GA 30084
Nir Sassi	officer: Chief Financial Officer	3 ELUL STREET, APT. 6, MODIIN L3 7176397
Nadav Navon	officer: Chief Operating Officer	18 LEA IMENU STREET MODIIN L3 7177945
Anthony J Maddaluna	director	PFIZER INC. ATTN CORPORATE SECRETARY, 235 RAST 42ND STREET, NEW YORK NY 10017
William B Hayes	director	231 MAPLE AVENUE, BURLINGTON NC 27215
Roger Pomerantz	director	711 HARVEST HILL ROAD, CHALFONT PA 18914
Hila Karah	director	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
John W Kozarich	director	10275 SCIENCE CENTER DR, SAN DIEGO CA 92121
Jeffrey A Meckler	director, officer: Chief Executive Officer	740 BROADWAY, 9TH FLOOR, NEW YORK NY 10003
R Michael Gendreau	officer: Chief Medical Officer	4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121
Dexcel Pharma Technologies Ltd.	10 percent owner	1 DEXCEL STREET, OR AKIVA L3 3060000
Dan Oren	10 percent owner	1 DEXCEL STREET, OR AKIVA L3 30600000
Gil Bianco	director	7 HAORANIM STREET BAZRA L3 60944